135 related articles for article (PubMed ID: 4015071)
1. Metabolism and disposition of amifloxacin in laboratory animals.
Johnson JA; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):774-81. PubMed ID: 4015071
[TBL] [Abstract][Full Text] [Related]
2. Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys.
McCoy LF; Crawmer BP; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):769-73. PubMed ID: 4015070
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
5. Determination of amifloxacin and two of its principal metabolites in plasma and urine by high-performance liquid chromatography using automated column switching.
Crawmer BP; Cook JA; Brown RR
J Chromatogr; 1990 Sep; 530(2):407-17. PubMed ID: 2127781
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of amifloxacin and two of its metabolites.
Venezia RA; Prymas LA; Shayegani A; Yocum DM
Antimicrob Agents Chemother; 1989 May; 33(5):762-6. PubMed ID: 2751287
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
[TBL] [Abstract][Full Text] [Related]
9. Amifloxacin distribution in the dog prostate.
Frimodt-Møller PC; Dørflinger T; Madsen PO
Prostate; 1985; 6(2):163-8. PubMed ID: 3975177
[TBL] [Abstract][Full Text] [Related]
10. Disposition of [14C]aztreonam in rats, dogs, and monkeys.
Kripalani KJ; Singhvi SM; Weinstein SH; Everett DW; Bathala MS; Dean AV; Ita CE; Lawrence L; Meeker FS; Shaw JM
Antimicrob Agents Chemother; 1984 Aug; 26(2):119-26. PubMed ID: 6541449
[TBL] [Abstract][Full Text] [Related]
11. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S
Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358
[TBL] [Abstract][Full Text] [Related]
12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).
Cornett JB; Wagner RB; Dobson RA; Wentland MP; Bailey DM
Antimicrob Agents Chemother; 1985 Jan; 27(1):4-10. PubMed ID: 3885845
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
18. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
Tang-Liu DD; Richman JB; Lin P; Selim S
Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K
Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
